Although NF1 mutations are risk factors for JMML, the presence of monosomy of chromosome 5, and low levels of fetal hemoglobin (HbF), were more indicative of secondary myelodysplastic/myeloproliferative syndrome (MDS/MPS). The gene discussed is NF1; the disease is myelodysplastic syndrome.